If it fails this company would be on the ropes with the lender Oaktree being merciless
This is a do or die …..that being said …having Krause on board guiding this through the regulatory hoops gives us a big fighting chance
That is why the shorts have hung around ….waiting for the buzzards flying above
80% chance of approval is about right
Cell Therapy News/Articles, page-16624
-
- There are more pages in this discussion • 1,406 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.005(0.50%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.00 | 98.5¢ | $401.6K | 405.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 15988 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 40424 | 6 |
View Market Depth
| Last trade - 10.25am 05/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |